RESUMO
PURPOSE: Accurate preoperative localization is imperative to facilitate a minimally invasive parathyroidectomy (MIP) in primary hyperparathyroidism (pHPT). This study aims to compare the diagnostic value of standard-of-care localization techniques (ultrasound [US] and 99mTechnetium (99mTc) -sestamibi scintigraphy) to [F-18]-fluorocholine positron emission tomography/magnetic resonance imaging (FCH-PET/MRI) to determine the additional clinical usefulness of PET/MRI in a Canadian cohort. METHODS: We conducted a prospective, appropriately powered, study to compare the diagnostic value of -FCH PET/MRI to that of the US and 99mTc-sestamibi scintigraphy for localization of parathyroid adenomas in a patient with pHPT. The primary outcome was the per-lesion sensitivity and positive predictive value (PPV) of FCH-PET/MRI, US, and 99mTc-sestamibi scintigraphy. Intraoperative surgeon localization, parathormone levels, and histopathological findings were used as reference standards. RESULTS: Forty-one patients underwent FCH-PET/MRI of which 36 patients had parathyroidectomy. In these 36 patients, 41 parathyroid lesions were histologically confirmed as adenomas or hyperplastic glands. Per-lesion sensitivity of FCH-PET/MRI was 82.9% and of US and 99mTc-sestamibi scintigraphy combined at 50.0%, respectively. The sensitivity of FCH-PET/MRI was superior to that of US and 99mTc-sestamibi scintigraphy (p = 0.002). In the 19 patients in whom both US and 99mTc-sestamibi scintigraphy were negative, PET/MRI correctly identified the parathyroid adenoma in 13 patients (68%). CONCLUSIONS: FCH-PET/MRI is a highly accurate imaging modality for localization of parathyroid adenomas in a tertiary center in North America. It is a superior functional imaging modality to 99mTc-sestamibi scintigraphy alone and more sensitive for localization of parathyroid lesions than US and 99mTc-sestamibi scintigraphy combined. This imaging modality could become the most valuable preoperative localization study given its superior performance in localizing parathyroid adenomas.
Assuntos
Hiperparatireoidismo Primário , Neoplasias das Paratireoides , Humanos , Neoplasias das Paratireoides/diagnóstico por imagem , Neoplasias das Paratireoides/cirurgia , Estudos Prospectivos , Hiperparatireoidismo Primário/cirurgia , Canadá , Tomografia por Emissão de Pósitrons/métodos , Glândulas Paratireoides/diagnóstico por imagem , Glândulas Paratireoides/cirurgia , Glândulas Paratireoides/patologia , Compostos Radiofarmacêuticos , Tecnécio Tc 99m Sestamibi , Compostos de Organotecnécio , Imageamento por Ressonância MagnéticaRESUMO
This review article discusses the diagnosis and treatment of patients with multiple endocrine neoplasia type 2 (MEN2). The most common tumors associated with MEN2 are those of the parathyroid, thyroid, and adrenal glands. Additional manifestations include characteristic clinical phenotypes or features as described in the article. This review provides an overview of clinical manifestations, screening, diagnosis, treatment, and surveillance of patients with MEN2.
RESUMO
BACKGROUND: Brain abscess in infants is extremely rare in the developed world. Often, these children have a predisposing history and are infected with certain bacterial aetiology. CASE HISTORY: A 3-month-old boy presented to the hospital emergently with an increased intracranial pressure crisis. All predisposing factors such as maternal history, family history or the infant's medical history were entirely free of suggestive aetiological pathology. Neuroimaging revealed a complex mass lesion for which differential diagnosis included neoplasm and brain abscess. We will report on the surgical and medical intervention as well as patient outcome. DISCUSSION: A focus will be placed on the rare pathology discovered and a short review of the literature on the aetiology of this child's brain lesion will be included as well as support for the management steps taken. CONCLUSIONS: Brain abscess in infants is often extremely serious and overwhelming. Concluding topics will focus on contradictions to expected outcome as well as prognostic prospects for patients with this type of devastating disease.